Loomis, Sayles & Company’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.7M | Sell |
856,887
-52,905
| -6% | -$2.57M | 0.05% | 129 |
|
|
2025
Q1 | $31M | Sell |
909,792
-1,173
| -0.1% | -$39.9K | 0.04% | 165 |
|
|
2024
Q4 | $35.9M | Sell |
910,965
-34,302
| -4% | -$1.35M | 0.05% | 162 |
|
|
2024
Q3 | $44.4M | Sell |
945,267
-60,946
| -6% | -$2.86M | 0.06% | 148 |
|
|
2024
Q2 | $54.3M | Sell |
1,006,213
-19,030
| -2% | -$1.03M | 0.07% | 106 |
|
|
2024
Q1 | $69.9M | Sell |
1,025,243
-42,108
| -4% | -$2.87M | 0.1% | 88 |
|
|
2023
Q4 | $66.8M | Sell |
1,067,351
-29,003
| -3% | -$1.82M | 0.1% | 91 |
|
|
2023
Q3 | $49.8M | Sell |
1,096,354
-51,575
| -4% | -$2.34M | 0.09% | 112 |
|
|
2023
Q2 | $64.4M | Sell |
1,147,929
-8,881
| -0.8% | -$499K | 0.1% | 93 |
|
|
2023
Q1 | $52.3M | Sell |
1,156,810
-31,511
| -3% | -$1.43M | 0.09% | 112 |
|
|
2022
Q4 | $48.3M | Sell |
1,188,321
-56,878
| -5% | -$2.31M | 0.1% | 114 |
|
|
2022
Q3 | $81.4M | Sell |
1,245,199
-151,059
| -11% | -$9.87M | 0.16% | 73 |
|
|
2022
Q2 | $84.9M | Buy |
1,396,258
+105,353
| +8% | +$6.4M | 0.16% | 68 |
|
|
2022
Q1 | $81M | Sell |
1,290,905
-25,218
| -2% | -$1.58M | 0.11% | 80 |
|
|
2021
Q4 | $99.7M | Buy |
1,316,123
+390,209
| +42% | +$29.6M | 0.12% | 75 |
|
|
2021
Q3 | $104M | Buy |
925,914
+17,262
| +2% | +$1.93M | 0.13% | 72 |
|
|
2021
Q2 | $147M | Buy |
+908,652
| New | +$147M | 0.18% | 64 |
|